- Home
- ALEC vs TBI Comparison
ALEC vs TBI Comparison
Compare ALEC & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | TBI |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.7M | 129.9M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALEC | TBI |
|---|---|---|
| Price | $2.19 | $3.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.83 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 854.3K | 265.1K |
| Earning Date | 05-25-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.39 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | N/A | $6.25 |
| Revenue Next Year | $45.24 | $3.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.87 | $3.44 |
| 52 Week High | $3.40 | $7.78 |
Technical Indicators
Market Signals| Indicator | ALEC | TBI |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 38.45 |
| Support Level | $1.82 | $3.44 |
| Resistance Level | $2.53 | $5.56 |
| Average True Range (ATR) | 0.21 | 0.24 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 43.38 | 39.54 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.